XOMA Corp

NASDAQ XOMAP

Data sourced from iex and EODHD
Download Data

XOMA Corp Free Cash Flow Per Share for the Trailing 12 Months (TTM) ending March 31, 2024: -0.48

XOMA Corp Free Cash Flow Per Share is -0.48 for the Trailing 12 Months (TTM) ending March 31, 2024, a -24.48% change year over year. Free Cash Flow per Share represents the amount of free cash flow generated per outstanding share of common stock. It provides insight into the per-share value of free cash flow and is commonly used in valuation analysis. A higher value suggests a potentially more favorable investment opportunity.
  • XOMA Corp Free Cash Flow Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was -0.38.
NASDAQ: XOMAP

XOMA Corp

CEO -
IPO Date Dec. 16, 2020
Location United States
Headquarters 2200 Powell Street, EmeryVille, CA, United States, 94608
Employees 13
Sector Healthcare
Industry Biotechnology
Description

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Similar companies

XOMAO

XOMA Corporation

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email